Department Of Biotechnology Supported COVID 19 Vaccine ZyCoV-D Begins Adaptive Phase I/II Clinical Trials
BIRAC has announced that ZyCoV-D, the plasmid DNA vaccine designed and developed by Zydus and partially funded by the Department of Biotechnology, Government of India has initiated Phase I/ II…
Share